Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.

To describe the effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen in naive HIV-1-infected patients, as there is a lack of data with this combination.

Detalhes bibliográficos
Autores: Curran, Adrian, Rojas, Jhon, Cabello, Alfonso, Troya, Jesus, Imaz, Arkaitz, Domingo, Pere, Martinez, Esteban, Ryan, Pablo, Gorgolas, Miguel, Podzamczer, Daniel, Knobel, Hernando, Gutierrez, Felix, Ribera, Esteban
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2016
País:España
Recursos:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p1623
Acesso em linha:https://fisabio.portalinvestigacion.com/publicaciones/1623
Access Level:acceso abierto
id ES_7bfbee6fd2fdc7e82d023a290c983e0f
oai_identifier_str oai:fisabio.fundanetsuite.com:p1623
network_acronym_str ES
network_name_str España
repository_id_str
spelling Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.Curran, AdrianRojas, JhonCabello, AlfonsoTroya, JesusImaz, ArkaitzDomingo, PereMartinez, EstebanRyan, PabloGorgolas, MiguelPodzamczer, DanielKnobel, HernandoGutierrez, FelixRibera, EstebanTo describe the effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen in naive HIV-1-infected patients, as there is a lack of data with this combination.OXFORD UNIV PRESS2016info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fisabio.portalinvestigacion.com/publicaciones/1623JOURNAL OF ANTIMICROBIAL CHEMOTHERAPYISSN: 03057453ISSNe: 14602091reponame:r-FISABIO. Repositorio Institucional de Producción Científicainstname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)Inglésinfo:eu-repo/semantics/openAccessoai:fisabio.fundanetsuite.com:p16232026-06-11T12:45:17Z
dc.title.none.fl_str_mv Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.
title Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.
spellingShingle Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.
Curran, Adrian
title_short Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.
title_full Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.
title_fullStr Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.
title_full_unstemmed Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.
title_sort Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.
dc.creator.none.fl_str_mv Curran, Adrian
Rojas, Jhon
Cabello, Alfonso
Troya, Jesus
Imaz, Arkaitz
Domingo, Pere
Martinez, Esteban
Ryan, Pablo
Gorgolas, Miguel
Podzamczer, Daniel
Knobel, Hernando
Gutierrez, Felix
Ribera, Esteban
author Curran, Adrian
author_facet Curran, Adrian
Rojas, Jhon
Cabello, Alfonso
Troya, Jesus
Imaz, Arkaitz
Domingo, Pere
Martinez, Esteban
Ryan, Pablo
Gorgolas, Miguel
Podzamczer, Daniel
Knobel, Hernando
Gutierrez, Felix
Ribera, Esteban
author_role author
author2 Rojas, Jhon
Cabello, Alfonso
Troya, Jesus
Imaz, Arkaitz
Domingo, Pere
Martinez, Esteban
Ryan, Pablo
Gorgolas, Miguel
Podzamczer, Daniel
Knobel, Hernando
Gutierrez, Felix
Ribera, Esteban
author2_role author
author
author
author
author
author
author
author
author
author
author
author
description To describe the effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen in naive HIV-1-infected patients, as there is a lack of data with this combination.
publishDate 2016
dc.date.none.fl_str_mv 2016
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fisabio.portalinvestigacion.com/publicaciones/1623
url https://fisabio.portalinvestigacion.com/publicaciones/1623
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv OXFORD UNIV PRESS
publisher.none.fl_str_mv OXFORD UNIV PRESS
dc.source.none.fl_str_mv JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
ISSN: 03057453
ISSNe: 14602091
reponame:r-FISABIO. Repositorio Institucional de Producción Científica
instname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname_str Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
reponame_str r-FISABIO. Repositorio Institucional de Producción Científica
collection r-FISABIO. Repositorio Institucional de Producción Científica
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869411556483137536
score 15.812455

Registos relacionados